Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.32 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30077693 | 0.84 | LPL (0.33) | LPLLIPGALDH1A1 | |
| SCHEMBL30077847 | 0.84 | LPL (0.41) | LPLLIPG | |
| SCHEMBL25173250 | 0.84 | LPL (0.41) | LPLLIPG | |
| SCHEMBL23668643 | 0.84 | LPL (0.33) | LPLLIPGALDH1A1 | |
| SCHEMBL29414003 | 0.81 | NQO2 (0.46) | LPLLIPGCYP1A2CYP2A6KDM4E | |
| SCHEMBL21459066 | 0.81 | NQO2 (0.46) | LPLLIPGCYP1A2CYP2A6KDM4E | |
| SCHEMBL23043783 | 0.78 | CYP2A6 (0.49) | LPLLIPGCYP1A2CYP2A6CSF1R | |
| SCHEMBL30640509 | 0.78 | CYP2A6 (0.49) | LPLLIPGCYP1A2CYP2A6CSF1R | |
| SCHEMBL24373694 | 0.77 | MAOA (0.34) | LPLLIPGKDM4E | |
| SCHEMBL29964335 | 0.77 | NQO2 (0.41) | LPLLIPGCYP1A2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210193931-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2021-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210193931-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE | TERT, ICOSLG, ELAVL1 | LPL 168/4885LIPG 802/4885HIF1A 4881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.